Showing results (11-20 of 849) with videos related to

Sort By:
Pageof 85
Cancer Cell International|July 20, 2019
Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancerChao Liu, Bin Xu, Qian Li, et al.
Disease Markers|February 24, 2022
IDH1 Mutation Induces HIF-1α and Confers Angiogenic Properties in Chondrosarcoma JJ012 CellsXiaoyu Hu, Luyuan Li, Josiane E Eid, et al.
Medical Oncology (Northwood, London, England)|July 26, 2011
The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapyYanqin Yang, Jize Xuan, Zhiqiang Yang, et al.
Cancers|January 8, 2023
Strategies to Optimize Treatment for Locally Advanced Rectal CancerXiaoyu Hu, Zhuang Xue, Kewen He, et al.
Cancer Letters|January 26, 2024
PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutationXiaoyu Hu, Mengyu Zhao, Menglin Bai, et al.
Oncotargets and Therapy|February 27, 2016
Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutationJing Liu, Ligang Xing, Xue Meng, et al.
Journal of Immunology Research|April 14, 2022
Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical CancerChao Liu, Xiaohui Li, Aijie Li, et al.
Practical Radiation Oncology|March 20, 2025
Patterns of Recurrence After D2 Radical Surgery for Gastric Cancer: Implications for Postoperative Radiation TherapyWenheng Jiang, Haohua Wang, Xiang Zhang, et al.
Cancer Cell International|May 14, 2019
Peripheral memory and naïve T cells in non-small cell lung cancer patients with lung metastases undergoing stereotactic body radiotherapy: predictors of early tumor responseChao Liu, Qinyong Hu, Bin Xu, et al.
Future Oncology (London, England)|November 16, 2018
Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapyDong Guo, Minghuan Li, Dawei Chen, et al.
Pageof 85